HealthCap — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
InCarda Therapeuticsincardatherapeutics.comOct 2017
Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings.
BiotechDigital HealthMedical DevicesBrisbane, US
Rangachari Narasimhan(Executive Officer, Director)McCarthy Reenie(Director)Grace Colon(Executive Officer, Director)Bischofberger Norbert(Director)Miller Samantha(Executive Officer)
Board seatJohan Christenson· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.